Antidote.me
Signal active
Organization
Contact Information
Overview
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical, Health Diagnostics
Founded
2010
Employees
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Antidote.me headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $6.3B in funding across 120 round(s). With a team of 51-100 employees, Antidote.me is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Antidote.me, raised $1.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
1
Lead Investors
0
Total Funding Amount
$52.1M
Details
2
Antidote.me has raised a total of $52.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2015 | Early Stage Venture | 13.5M | ||
| 2013 | Early Stage Venture | 3.2M |
Investors
Antidote.me is funded by 35 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Amadeus Capital Partners | - | FUNDING ROUND - Amadeus Capital Partners | 3.2M |
| Alex van Someren | - | FUNDING ROUND - Alex van Someren | 1.2M |
| Antidote.me | - | FUNDING ROUND - Antidote.me | 1.2M |
| Amadeus Capital Partners | - | FUNDING ROUND - Amadeus Capital Partners | 1.2M |
Recent Activity
There is no recent news or activity for this profile.